Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Icro Meattini is a leading radiation oncologist whose research is reshaping the treatment landscape for early breast cancer and complex oligometastatic disease. His most impactful work centers on the innovative application of stereotactic body radiotherapy (SBRT) and robotic radiosurgery. Dr. Meattini is perhaps best known for his leadership of the phase II ROCK trial, a landmark study investigating preoperative robotic radiosurgery for early breast cancer. This work, which has garnered significant attention, explores the critical advantage of treating a well-defined target before surgery, potentially revolutionizing partial breast irradiation. Beyond breast cancer, Dr. Meattini has made seminal contributions to the use of CyberKnife SBRT for challenging cardiac malignancies, demonstrating the feasibility of delivering focused, high-dose radiation to the heart. His research also extends to the effective management of abdominal lymph node metastases, where his studies on linac-based and robotic SBRT have provided crucial clinical outcome data. With his most cited papers accumulating dozens of citations, Dr. Meattini’s work is a driving force in advancing high-precision, non-invasive cancer therapies, offering new hope for patients with traditionally difficult-to-treat tumors.